Rozebalamin, an ultra-high dose vitamin B12 treatment, was approved in Japan to slow disease progression in people with ALS.

This comes after drug manufacturers issued applications to increase prices due to increased cost of ingredients, production, ...

Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the retail price of 20 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013. These drugs are used for ...

In a doctor-led clinical trial, the drug, mecobalamin, extended the survival period of patients within a year of the onset of ALS by over 500 days, surpassing existing drugs. It is the third ...